Assessment of ultrasound flow‑mediated dilation of brachial artery in regular blood donors in a Nigerian Tertiary Hospital
Article Sidebar
Views | PDF/EPUB Downloads:
14
/ 1
/ 1
Main Article Content
Abstract
Background: Iron is a pro-oxidant cofactor that may be linked to cardiovascular disease (CVD) progression and reduction of body iron stores have been hypothesized to reduce the risk of CV disease.
Aim: The aim of this study is to assess reduction in CVD risk susceptibility among regular blood donors compared with nondonors using ultrasound brachial artery flow-mediated dilation (BAFMD).
Settings and Design: A prospective comparative study designed to establish the difference between mean flow-mediated dilatation (FMD) in the patients who are regular blood donors compared with nondonors recruited from a Teaching Hospital donor clinic.
Materials and Methods: Data were collected over 7 months from December 2014 to June 2015. 100 eligible regular male blood donors, aged 21–50 years, were selected from a Teaching Hospital blood donor records and their BAFMD assessed. 50 nondonors/first time donors, of equivalent age group, consecutively were assessed for comparison. Serum markers of iron stores, markers of oxidative stress and other related cardiac risk factors were also assessed in all patients.
Results: BAFMD was significantly greater in regular blood donors when compared with nondonors (13.95% ± 7.02% vs. 8.20% ± 4.19%, P = 0.000). Serum ferritin was significantly decreased in regular blood donors when compared with nondonors (mean value 41.92 ng/ml ± 23.12 ng/ml vs. 61.97 ± 30.19 ng/ml, P = 0.000), but Hb did not differ between the groups. High FMD was significantly associated with high C-high-density lipoprotein and low C-LDL (r = −0.215*, P = 0.032, r = 0.188, P = 0.031, r = 0.193, P = 0.027, r = 0.0279,
P = 0.002, r = 0.139, P = 0.084). LDL was decreased in regular blood donors compared with nondonors.
Conclusion: The study provides prognostic information for assessing ultrasound BAFMD as a cardiac risk marker. Regular blood donors have enhanced cardiovascular function with increased flow-mediated dilation, decreased body iron stores, and decreased oxidative stress compared with nondonors.
Downloads
Article Details
Section
How to Cite
References
1. BeLue R, Okoror TA, Iwelunmor J, Taylor KD, Degboe AN, Agyemang C, et al. An overview of cardiovascular risk factor burden in sub‑Saharan African countries: A socio‑cultural perspective. Global Health 2009;5:10.
2. Cristiane MS, Hilton AK, Carlos AB. Brachial artery flow‑mediated dilatation and intima‑media thickness of carotid and brachial arteries: Evaluation of individuals with and without risk factors for atherosclerosis. Radiol Bras 2010;43:389‑439.
3. Ezeanyika LU, Ugwu CE, Nwanguma BC. Assessment of cardiovascular disease risk factor of an urban Nigeria hypertensive population using a risk score calculator. Pak J Med Sci 2008;24:390‑4.
4. World Health Organisation. The Impact of Chronic Disease in Nigeria. Available from: http://www.who.int/chp/chronic_disease_report/media/NIGERIA.pdf. [Last accessed on 2018 Jan 12].
5. Kadiri S. Tackling cardiovascular disease in Africa. BMJ 2005;331:711‑2.
6. Akinboboye O, Idris O, Akinboboye O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in sub‑Saharan Africans. J Hum Hypertens 2003;17:381‑7.
7. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation 2007;115:1285‑95.
8. Sani MU, Wahab KW, Yusuf BO, Gbadamosi M, Johnson OV, Gbadamosi A, et al. Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population – A cross sectional study. BMC Res Notes 2010;3:11.
9. Ejim EC, Okafor CI, Emehel A, Mbah AU, Onyia U, Egwuonwu T, et al. Prevalence of cardiovascular risk factors in the middle‑aged and elderly population of a Nigerian rural community. J Trop Med 2011;2011:308687.
10. Jadrić R, Hasić S, Kiseljaković E, Corić J, Prnjavorac B, Winterhalter‑Jadrić M, et al. Blood iron stores reduction affects lipoprotein status – A potential benefit of blood donation. Med Glas (Zenica) 2011;8:146‑50.
11. Hu FB. The iron‑heart hypothesis: Search for the ironclad evidence. JAMA 2007;297:639‑41.
12. Al‑Qaisi M, Kharbanda RK, Mittal TK, Donald AE. Measurement of endothelial function and its clinical utility for cardiovascular risk. Vasc Health Risk Manag 2008;4:647‑52.
13. Zheng H, Cable R, Spencer B, Votto N, Katz SD. Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol 2005;25:1577‑83.
14. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial‑dependent flow‑mediated vasodilation of the brachial artery: A report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002;39:257‑65.
15. Rudolph TK, Ruempler K, Schwedhelm E, Tan‑Andresen J, Riederer U, Böger RH, et al. Acute effects of various fast‑food meals on vascular function and cardiovascular disease risk markers: The Hamburg burger trial. Am J Clin Nutr 2007;86:334‑40.
16. van Jaarsveld H, Pool GF. Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein. Atherosclerosis 2002;161:395‑402.
17. Fuster V, Voute J, Hunn M, Smith SC Jr. Low priority of cardiovascular and chronic diseases on the global health agenda: A cause for concern. Circulation 2007;116:1966‑70.
18. Newcomer SC, Leuenberger UA, Hogeman CS, Proctor DN. Heterogeneous vasodilator responses of human limbs: Influence of age and habitual endurance training. Am J Physiol Heart Circ Physiol 2005;289:H308‑15.
19. Wray DW, Uberoi A, Lawrenson L, Richardson RS. Evidence of preserved endothelial function and vascular plasticity with age. Am J Physiol Heart Circ Physiol 2006;290:H1271‑7.
20. Jensen-Urstad K, Johansson J. Gender difference in age-related changes in vascular function. J Intern Med 2001;250:29-36.
21. Malik J, Melenovsky V, Wichterle D, Haas T, Simek J, Ceska R, et al. Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial – FAT). Cardiovasc Res 2001;52:290‑8.
22. Fernández‑Real JM, López‑Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem 2005;51:1201‑5.
23. Adias TC, Igwilo AC, Awortu ZJ. Repeat whole blood donation correlates significantly with reductions in BMI and lipid profiles and increased gamma glutamic transferase (GGT) activity among Nigerian blood donors. Open J Blood Dis 2012;2:90‑4.
24. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001;103:52‑7.
25. Tuomainen TP, Salonen R, Nyyssönen K, Salonen JT. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in Eastern Finland. BMJ 1997;314:793‑4.
26. Salonen JT, Tuomainen TP, Salonen R, Lakka TA, Nyyssönen K. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio ischaemic heart disease risk factor study. Am J Epidemiol 1998;148:445‑51.
27. Klipstein‑Grobusch K, Grobbee DE, den Breeijen JH, Boeing H, Hofman A, Witteman JC, et al. Dietary iron and risk of myocardial infarction in the Rotterdam study. Am J Epidemiol 1999;149:421‑8.
28. Orimadegun BE, Anetor JI, Adedapo DA, Taylor GO, Onuegbu JA, Olisekodiaka JM. Increased serum iron associated with coronary heart disease among Nigerian adults. Pak J Med Sci 2007;23:518‑22.
29. Adediran A, Uche EI, Adeyemo TA, Damulak DO, Akinbami AA, Akanmu AS, et al. Iron stores in regular blood donors in Lagos, Nigeria. J Blood Med 2013;4:75‑80.
30. Usanga EA. Iron stores of Nigerian blood donors as assessed by serum ferritin concentration. Cent Afr J Med 1990;36:170‑3.
31. Linpisarn S, Thanangkul O, Suwanraj C, Kaewvichit R, Kricka LJ, Whitehead TP, et al. Iron deficiency in a Northern Thai population: The effects of iron supplements studied by means of plasma ferritin estimations. Ann Clin Biochem 1984;21(Pt 4):268‑74.
32. Milman N, Kirchhoff M. The influence of blood donation on iron stores assessed by serum ferritin and hemoglobin in a population survey of 1359 Danish women. Ann Hematol 1991;63:27‑32.
33. Meyers DG, Jensen KC, Menitove JE. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002;42:1135‑9.
34. Mackintosh W, Jacobs P. Response in serum ferritin and haemoglobin to iron therapy in blood donors. Am J Hematol 1988;27:17‑9.
35. Akpotuzor JO, Isong C, Okpokam DC, Etukudo MH. Levels of serum iron, TIBC, transferrin saturation and PCV in blood donors in Calabar cross rivers state, Nigeria. Pak J Nutr 2008;7:500‑2.
36. Bharadwaj RS. A study of lipid profiles among male voluntary blood donors in Chennai city. Indian J Community Med 2005;30:16‑23.
37. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Laupacis A, et al. Ischemic heart disease risk factors in blood donors and non donors. J Clin Epidemiol 1996;49:1409‑14.
38. Rautaharju PM, Carrier GW, Chaitman BR, Levy D, Prineas RJ, Cheng S, et al. Risk factors for coronary heart disease in blood donors and non donors in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1983;117:624‑37.
39. Danesh J, Collins R, Peto R. Blood donation and ischemic heart disease: Meta analysis of 7 prospective studies. Lancet 1999;353:1767‑70.
40. Rose G, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2nd ed. Geneva: World Health Organization; 1982.
41. Suessenbacher A, Frick M, Alber HF, Barbieri V, Pachinger O, Weidinger F, et al. Association of improvement of brachial artery flow‑mediated vasodilation with cardiovascular events. Vasc Med 2006;11:239‑44.
42. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002;40:505‑10.
43. Fathi R, Haluska B, Isbel N, Short L, Marwick TH. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 2004;43:616‑23.
44. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr., et al. Clinical correlates and heritability of flow‑mediated dilation in the community: The Framingham heart study. Circulation 2004;109:613‑9.
45. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804‑9.
46. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: Protective effect of Vitamin C. Diabetes 2001;50:159‑65.
47. Peña AS, Wiltshire E, MacKenzie K, Gent R, Piotto L, Hirte C, et al. Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children. J Clin Endocrinol Metab 2006;91:4467‑71.
48. Meroño T, Gómez L, Sorroche P, Boero L, Arbelbide J, Brites F, et al. High risk of cardiovascular disease in iron overload patients. Eur J Clin Invest 2011;41:479‑86.
49. Berge LN, Bønaa KH, Nordøy A. Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women. Arterioscler Thromb 1994;14:857‑61.
50. Uche E, Adediran A, Damulak O, Adeyemo T, Akinbami A, Akanmu A, et al. Lipid profile of regular blood donors. J Blood Med 2013;4:39‑42.
51. Szymczyk‑Nuzka M, Wołowiec D. Iron stores in regular blood donors. Pol Arch Med Wewn 2003;110:1415‑21.
52. Flesland O, Eskelund AK, Flesland AB, Falch D, Solheim BG, Seghatchian J, et al. Transferrin receptor in serum. A new tool in the diagnosis and prevention of iron deficiency in blood donors. Transfus Apher Sci 2004;31:11‑6.
53. Djalali M, Neyestani TR, Bateni J, Siassi F. The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization. Int J Vitam Nutr Res 2006;76:132‑7.
54. Jeremiah ZA, Koate BB. Anaemia, iron deficiency and iron deficiency anaemia among blood donors in Port Harcourt, Nigeria. Blood Transfus 2010;8:113‑7.
55. Okpokam DC, Emeribe AO, Akpotuzor JO. Frequency of blood donation and iron stores of blood donors in Calabar, Cross River, Nigeria. Int J Biomed Lab Sci 2012;1:40‑3.